Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.

Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedVersion update from v3.1.0 to v3.2.0 with new funding/status notices and a new genetic disorder topic.SummaryDifference4%
- Check16 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.6%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page updates from Revision: v3.0.1 to v3.0.2, signaling a minor update; the 'Back to Top' link was removed, a small navigational change with no evident impact on core content.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional publications related to drug safety and specific medical conditions. Notably, the drug 'plozasiran' is highlighted, indicating a focus on its management of certain diseases.SummaryDifference18%
- Check59 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.